Dynamics of Renal Fibrosis Markers on the Basis of Complex  Treatment in Chronic Heart Failure with Anemia

Tosheva Khakima Bekmurodovna, Gadaev Abdigaffar Gadaevich

dc.contributor.author	Tosheva Khakima Bekmurodovna, Gadaev Abdigaffar Gadaevich
dc.date.accessioned	2021-12-28T08:47:53Z
dc.date.available	2021-12-28T08:47:53Z
dc.date.issued	2021
dc.identifier.issn	0033-3077
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/1220
dc.description.abstract	Renal fibrosis markers were evaluated in dynamics to study specific changes in the kidneys of patients with different hemodynamic types and functional classes of chronic heart failure with anemia and to evaluate the effectiveness of complex treatment. The renal fibrosis marker TGF-β1in the blood was 2591.0 ± 108.4 and 755.0 ± 18.87 pg / ml, respectively, in the absence of chronic heart failure and anemia (p˂0.001). This was indicative of a fibrosis process occurring in the kidney. After complex treatment with iron supplements, the TGF-β1index decreased by 2.25 times (p (0.001), the clinical condition, quality of life and endurance to physical activity changed significantly positively	en_US
dc.language.iso	en	en_US
dc.subject	chronic heart failure, chronic kidney disease, renal dysfunction, fibrosis markers, anemia, anemia, hemoglobin, iron in the blood, hemodynamic types	en_US
dc.title	Dynamics of Renal Fibrosis Markers on the Basis of Complex Treatment in Chronic Heart Failure with Anemia	en_US
dc.type	Article	en_US